Alzheimer’s Disease Therapeutics Market Size, Share, and Growth Forecast 2026 – 2033

The global Alzheimer’s Disease Therapeutics Market size is expected to be valued at US$ 5.4 billion in 2026 and projected to reach US$ 10.1 billion by 2033, growing at a CAGR of 9.2% between 2026 and 2033. The primary stems from the rise in prevalence of Alzheimer's disease due to an aging population worldwide, coupled with breakthroughs in disease-modifying therapies that promise better patient outcomes.

For instance, recent approvals of monoclonal antibodies have shifted focus from symptomatic relief to slowing disease progression, supported by increased R&D investments from leading pharmaceutical firms. Additionally, rising awareness campaigns by organizations like the Alzheimer's Association and favorable reimbursement policies in key regions are accelerating market expansion by improving access to innovative treatments.